Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Joseph Potz
TG4010 Immunotherapy Combined With First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Phase IIb Results of the TIME Study
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Cost-Effectiveness of First-Line Therapy for Advanced Non-Small Cell Lung Cancer (Nsclc)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Immunotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Redefining Treatment Paradigms in First-Line Advanced Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
P1.01-109 Phase I Study of Apatinib Plus Gefitinib as First-Line Therapy in Patients With EGFR Mutant Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Efficacy and Safety of Icotinib as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Phase II Study of Gemcitabine Plus Oxaliplatin as First-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Immunotherapy at Any Line of Treatment Improves Survival in Patients With Advanced Metastatic Non‐small Cell Lung Cancer (NSCLC) Compared With Chemotherapy (Quijote‐CLICaP)
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Potential Role of Immunotherapy in Advanced Non-Small-Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
